Rumi competitive analysis

Explore patent oppositions filed by Rumi against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Apr 30, 2026
Patent NumberTitleApplicantOpposition Date
Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their PreparationBOEHRINGER INGELHEIMOct 21, 2025
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 8, 2025
Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSApr 29, 2025
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 24, 2025
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 14, 2024
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 6, 2024
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 17, 2024
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 10, 2024
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSAug 1, 2024

Explore Rumi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Apr 30, 2026
Patent NumberPublication DateTitleTotal Oppositions
May 1, 2024Improvements To Devices And Methods For Delivery Of Substances To Animals1

Latest PTAB cases involving Rumi

Discover the latest PTAB cases involving Rumi, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Rumi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Apr 30, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LUIGI17 - - -
BOEHRINGER INGELHEIM49182109
REGENERON PHARMACEUTICALS3894932
SANOFI BIOTECHNOLOGY - 51 - -